Table 4.
Predictors of Option B+ PMTCT Adherence Among Pregnant and Lactating Women on Option B+ at Ilu Abba Bor and Buno Bedelle Zones, Oromia, Ethiopia, 2018
| Variables | Adherence Level | COR 95% CI | AOR95% CI | ||
|---|---|---|---|---|---|
| Good Adherence | Poor Adherence | ||||
| 1. Where do you living? | Urban | 115(78.8%) | 21(61.8%) | 2.3(1.04, 5.1) | 0.45(0.03, 6.5) |
| Rural | 31(21.2%) | 13(38.2%) | 1 | 1 | |
| 2. Hours it takes to reach the health facility | <1hr | 91(62.3%) | 12(35.3%) | 3(1.5,6.2) | 0.4(0.9, 2.4) |
| >1hr | 55(37.7%) | 22(64.7%) | 1 | 1 | |
| 3. Participation of mother in mother discussion about ART | Yes | 97(66.4%) | 12(35.3%) | 3.6(1.6,8) | 0.01(0.01, 9) |
| No | 49(33.6%) | 22(64.7%) | 1 | 1 | |
| 4. Social and financial support | Yes | 84(57.5%) | 15(44.1%0 | 1.7(0.8, 3.6) | 5(1.8, 17)** |
| No | 62(42.5%) | 19(55.9%0 | 1 | 1 | |
| 5. When knowing HIV status | Before pregnancy | 84(57.5%) | 9(26.5%) | 3.8(1.6, 8.6) | 0.02(0, 1.4) |
| While pregnancy | 62(42.5%) | 25(73.5%) | 1 | 1 | |
| 6. HIV status disclosure | Yes | 96(65.8%) | 14(41.2%) | 2.7(1.3, 5.9) | 2(1.8, 2.5)** |
| No | 50(34.2%) | 20(58.8%) | 1 | 1 | |
| 7. support after disclosure | Yes | 140(89.7%) | 16(71.4%) | 3.4(0.9, 12.9) | 0.01(0.01, 1.6) |
| No | 20(10.3%) | 4(28.6%) | 1 | 1 | |
| 8.Counseled on ART side effect | Yes | 135(92.5%) | 15(44.1%) | 15.5(6.2, 38) | |
| No | 11(7.5%) | 19(55.9%) | 1 | 1 | |
| 9. Counseled on HIV | Yes | 133(91.1%) | 16(47.1%) | 11.5(4.7, 27) | |
| No | 13(8.9%) | 18(52.9%) | 1 | ||
Note: **Indicates the significant variables on the final model.
Abbreviations: HIV, human immune virus; ART, antiretroviral treatment; Hrs, hours; PMTCT, prevention of mother to child transmission; AOR, adjusted odds ratio; CI, confidence interval; COR, crude odds ratio.